About the Authors

Gordon D. Schiff
Brigham and Woman's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

Gordon D. Schiff, William L. Galanter, Jay Duhig, Michael J. Koronkowski, Amy E. Lodolce, Pam Pontikes, John Busker, Daniel Touchette, Surrey Walton, Bruce L. Lambert
Center for Education and Research on Therapeutics, University of Illinois at Chicago, Chicago, Illinois, United States of America

William L. Galanter
University of Illinois at Chicago, College of Medicine, Chicago, Illinois, United States of America

William L. Galanter, Bruce L. Lambert
Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, United States of America

Jay Duhig, Michael J. Koronkowski, Amy E. Lodolce, Daniel Touchette, Surrey Walton, Bruce L. Lambert
University of Illinois at Chicago, Department of Pharmacy Administration, Chicago, Illinois, United States of America

Pam Pontikes, John Busker
John H. Stroger Jr. Hospital of Cook County, Chicago, Illinois, United States of America

Corresponding Author

gschiff@partners.org

Competing Interests

WG received grant funding from Abbott Labs- 2% FTE this year, Consulting with Walgreens (member of P&T Committee, ∼$5,000). JD had a summer student internship with Abbott Laboratories in Regulatory Affairs 2009–2010 7 k (2009) 8 k (2010). SW consulted for Abbott, Genentech, Primus. MK is a Consultant Pharmacist, Pharmacy and Therapeutics Committee, Catalyst Health Solutions, Inc, Rockville, MD. DT received unrestricted grant funding for research from Medco Health Solutions. BL consulted in last 3 years: Abbott (drug name confusion), Transcept. Stock ownership: Pharm I.R., Inc. (my own company, specializing in preventing and detecting drug name confusion errors). Expert witness testimony: Hernandez v. Schering (for Hernandez), Mason v. General Electric Company, et al. (for Mason). Grants received: Abbott (readability of MedGuides), Novartis (development of pharmacoepidemiologic methods), Ortho McNeil (safety of warfarin post orthopedic surgery), AHRQ (Tools for Optimizing Prescribing). Patents received: BLL Consulting, Inc. (related to preventing drug name confusions) Other: Board of Directors (unpaid) for Med-Errs, Inc. (drug name confusion).

Author Contributions

Analyzed the data: GS WG JD MK AL PP JB DT SW BL. Wrote the first draft of the manuscript: GS BL WG. Contributed to the writing of the manuscript: GS WG JD MK AL PP JB DT SW BL. ICMJE criteria for authorship read and met: GS WG JD MK AL PP JB DT SW BL. Agree with manuscript results and conclusions: GS WG JD MK AL PP JB DT SW BL. Obtained funding: GS BL.